174 related articles for article (PubMed ID: 18590460)
1. Photosensitiser delivery for photodynamic therapy. Part 1: Topical carrier platforms.
Donnelly RF; McCarron PA; Morrow DI; Sibani SA; Woolfson AD
Expert Opin Drug Deliv; 2008 Jul; 5(7):757-66. PubMed ID: 18590460
[TBL] [Abstract][Full Text] [Related]
2. Innovative drug delivery strategies for topical photodynamic therapy using porphyrin precursors.
Morrow DI; Garland MJ; McCarron PA; Woolfson AD; Donnelly RF
J Environ Pathol Toxicol Oncol; 2007; 26(2):105-16. PubMed ID: 17725536
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery systems for photodynamic therapy.
Donnelly RF; McCarron PA; Woolfson D
Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):1-7. PubMed ID: 19149725
[TBL] [Abstract][Full Text] [Related]
4. Liposomes in topical photodynamic therapy.
Dragicevic-Curic N; Fahr A
Expert Opin Drug Deliv; 2012 Aug; 9(8):1015-32. PubMed ID: 22731896
[TBL] [Abstract][Full Text] [Related]
5. Drug delivery of aminolevulinic acid from topical formulations intended for photodynamic therapy.
Donnelly RF; McCarron PA; Woolfson AD
Photochem Photobiol; 2005; 81(4):750-67. PubMed ID: 15790300
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy using topically applied hypericin: comparative effect with methyl-aminolevulinic acid on UV induced skin tumours.
Boiy A; Roelandts R; de Witte PA
J Photochem Photobiol B; 2011 Feb; 102(2):123-31. PubMed ID: 21035351
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and tolerability of 5-aminolevulinic acid 5% thermosetting gel photodynamic therapy (PDT) in the treatment of mild-to-moderate acne vulgaris. A two-center, prospective assessor-blinded, proof-of-concept study.
Serini SM; Cannizzaro MV; Dattola A; Garofalo V; Del Duca E; Ventura A; Milani M; Campione E; Bianchi L
J Cosmet Dermatol; 2019 Feb; 18(1):156-162. PubMed ID: 29790262
[TBL] [Abstract][Full Text] [Related]
8. Retained topical delivery of 5-aminolevulinic acid using cationic ultradeformable liposomes for photodynamic therapy.
Oh EK; Jin SE; Kim JK; Park JS; Park Y; Kim CK
Eur J Pharm Sci; 2011 Sep; 44(1-2):149-57. PubMed ID: 21782942
[TBL] [Abstract][Full Text] [Related]
9. The influence of the vehicle on the synthesis of porphyrins after topical application of 5-aminolaevulinic acid. Implications in cutaneous photodynamic sensitization.
Casas A; Fukuda H; Di Venosa G; Batlle AM
Br J Dermatol; 2000 Sep; 143(3):564-72. PubMed ID: 10971330
[TBL] [Abstract][Full Text] [Related]
10. Topical methotrexate pretreatment enhances the therapeutic effect of topical 5-aminolevulinic acid-mediated photodynamic therapy on hamster buccal pouch precancers.
Yang DF; Lee JW; Chen HM; Hsu YC
J Formos Med Assoc; 2014 Sep; 113(9):591-9. PubMed ID: 24811932
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy with 5-aminolevulinic acid induces distinct microcirculatory effects following systemic or topical application.
Schacht V; Szeimies RM; Abels C
Photochem Photobiol Sci; 2006 May; 5(5):452-8. PubMed ID: 16685321
[TBL] [Abstract][Full Text] [Related]
12. Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema.
Mikolajewska P; Iani V; Juzeniene A; Moan J
Br J Dermatol; 2009 Nov; 161(5):1173-9. PubMed ID: 19785604
[TBL] [Abstract][Full Text] [Related]
13. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
[TBL] [Abstract][Full Text] [Related]
14. Potential of microneedles in enhancing delivery of photosensitising agents for photodynamic therapy.
Kearney MC; Brown S; McCrudden MT; Brady AJ; Donnelly RF
Photodiagnosis Photodyn Ther; 2014 Dec; 11(4):459-66. PubMed ID: 25291556
[TBL] [Abstract][Full Text] [Related]
15. Our PDT experience in the treatment of non-melanoma skin cancer over the last 7 years.
Baptista J; Martinez C; Leite L; Cochito M
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):693-7. PubMed ID: 16836497
[TBL] [Abstract][Full Text] [Related]
16. Topical photodynamic therapy in dermatology.
Szeimies RM; Calzavara-Pinton P; Karrer S; Ortel B; Landthaler M
J Photochem Photobiol B; 1996 Nov; 36(2):213-9. PubMed ID: 9002264
[TBL] [Abstract][Full Text] [Related]
17. Photosensitiser delivery for photodynamic therapy. Part 2: systemic carrier platforms.
Sibani SA; McCarron PA; Woolfson AD; Donnelly RF
Expert Opin Drug Deliv; 2008 Nov; 5(11):1241-54. PubMed ID: 18976134
[TBL] [Abstract][Full Text] [Related]
18. Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolaevulinic acid 20% vs. two-stage topical methyl aminolaevulinate: results of a randomized controlled trial.
Kessels JPHM; Kreukels H; Nelemans PJ; Roozeboom MH; van Pelt H; Mosterd K; de Haas ERM; Kelleners-Smeets NWJ
Br J Dermatol; 2018 May; 178(5):1056-1063. PubMed ID: 28886209
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy.
Chen HM; Yu CH; Tu PC; Yeh CY; Tsai T; Chiang CP
Lasers Surg Med; 2005 Aug; 37(2):114-22. PubMed ID: 16037967
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.
Fink-Puches R; Soyer HP; Hofer A; Kerl H; Wolf P
Arch Dermatol; 1998 Jul; 134(7):821-6. PubMed ID: 9681345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
